Stock Market Investing News

where to invest now newsletter

Stock Market Investing News

January 2, 2017

Market Strategies Newsletter – Sample Issue


Balanced Investing Strategies To Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (

Contributing Staff: Michael King, Charles Moskowitz

Where to invest market strategies

Stock Market Investing News and 

Where To Invest In Up Or Down Markets Newsletter Covering:


Options Trading Alerts

Options Trading Strategies

Stock Options Trading Alerts

Best Option Trading Strategies


Best Stocks To Invest In

Top Stocks To Invest In

Stocks To Invest In Now

Stock Market Investing News



Proven Profits Trading Success

Results From Our Recent Trade Alerts:


148% Profits on NVDA January 115 Puts in 2 Days

50% Loss on VRX December 30th 14 Calls in 11 Days

50% Loss on TLT December 23rd 119 Calls in 3 Days

19% Profits on XLF December 23.50 Puts in 6 days

163% Profits on SJM December 130 Calls in 23 days

37% Profits on GSK Jan 38 Calls for in 8 days

50% Loss on TLT December 23rd 119 Calls in 3 days

100% Profits on SJM December 130 Calls in 3 days

340% Profits on SIG November 85 Calls in 10 Days

93% Profits SPY November 9th 212 in 3 Days

100% Loss on SPY November 11th 210 Puts in 2 Days

58% Profits on SPY November 2 214 Puts in 9 Days

109% Profits on SPY November 2 214 Puts in 8 Days

58% Profits on SPY Nov 2 Puts n 3 Days

55% Loss on SPY Oct 28 Puts in 5 Days

123% Profits on SPY Oct 19 Puts in 2 Days

300% Profits on SPY Oct 12 Puts in 2 Days

15% Profits on SPY Oct 19 Puts in 2 Days


Join Today to Start Getting Profits Like These.


We Do The Analysis Work
We Send You The Trades
You Make The Trades
You Take Your Gains

NOTE: This is a Sample Issue Only!





For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:



Go To

To get the lowest full membership rates available now.



Options Trading Alerts

Options Trading Strategies

$10,000 Trading Portfolio
Charles Moskowitz Discussion




Well, Santa clearly skipped over Broad and Wall again this year with the Xmas to New Year loss on 3 of the 4 days amounting to 167.66.  Not a terrible loss in the context of the year but certainly not a Santa Claus rally.


This was the year that the pollsters had it all wrong every time there was a big question; Columbia, Italy, Brexit and of course the U.S. Presidential election.  All of those “in the know” had absolutely not even a clue as to what the people wanted.  And the media was the worst of the worst.  Bringing it back to the economy and the market, we also relied on the Fed to “guide” the monetary policies for us.  Is there a group that has gotten it any more wrong than them?  They have been wrong in their judgement about where we are and their projections about where we were headed.  Clearly these are two groups that have been useless to follow.  Unbelievable as it may seem, the US is not the center of the universe and while we may be the best house in a rapidly declining neighborhood, things are only better when compared to India, China and the other poor performers.


On the sentiment side the Bulls are running at 45.6% or almost 20% over the long term average with the Bears at 25.7%, 20% below average.  For most of the year we were mostly indecisive with the neutral side running very high. Right now, even at these lofty levels 74.3% of those surveyed are either bullish or neutral.  This is not a good setup for a market that has held off taking profits until the new year to take advantage of the “expected” changes in the tax laws.  I expect we will start to see the selling begin almost Immediately this  week.


The bottom line to me is that the market has discounted all of the good news and has become priced for perfection, and as we all know, this President is far from perfect.  His relationship with the press and even his own party is strained at best.  I expect him to have no “honeymoon” period and that leaves a lot of places for disappointment.  CAM


Stock Options Trading Alerts

Best Option Trading Strategies

Market Strategies $10,000 Trading Account Trade Table

Sold 1 NVDA January 115 Put
     740 Gain
Bought 4 AMBA January 57 Calls
Bought 1 NVDA January 115 Put
Sold 4 VRX December 30th 14 Calls
     148 Loss
Bought 4 LMT January 260 Calls
Bought 4 VRX December 30th 14 Calls


3rd Week expiration when the month is listed without a date


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


Remember, these trades are based on your participation in the

Subscriber Members Only



New Trades Will Be TEXTED To MEMBERS                                          


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:

Investing Trade Alerts Service



Go To

To get the lowest full membership rates available now.


Stocks To Invest In Now

Best Stocks To Invest In

Undervalued Small Cap Stocks


Lower Priced stocks that look to be a buy:


Repro-Med Systems, Inc  ( OTCQX:  REPR 0.50 )*   


Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced its financial results for the third quarter of the fiscal year ending February 28, 2017. For the quarter ended November 30, 2016, net revenues were $3,193,113, an increase of 1.5% compared with $3,144,954 in the same quarter last year.  This also represents an increase of 1.4% versus the last quarter.

For the nine months ended November 30, 2016, net revenues were $9,331,208, an increase of 4.4% compared with $8,941,676 for the same period last year, driven by increased sales of our infusion products to existing customers as well as the addition of new customers.  Excluding non-recurring clinical trial work in 2015, core revenue is up 6.5% for the most recent nine months.


There is a new application for our High Flo Subcutaneous needle sets for treatment of Parkinson’s disease, which is an entirely new market for us.  We have new trials going on all over Europe, and the possibility of one in Russia, in partnership with several pharmaceutical companies.  We’ll soon have trials in Germany, Sweden, and probably Italy. We are preparing a new market launch of an addition to our system designed for Facilitated Subcutaneous Immune Globulin (FSCIg) which was subject of a Swedish trial, and was such a hit (human factors study showed 95% out of 100 satisfaction), that patients are lining up and building pressure for us to begin delivery which we are working hard to accomplish.


This new system is also under trial in Germany.  For the first time patients are able to perform the delivery at home without nursing support.  We are working with large Pharma companies to deliver their new drugs to our markets widening the market for our High Flo 24 gauge needles.


The Europe team is comprised of impressive individuals. They each bring unique talents and collectively Andy believes they are unstoppable. Chatarina S., Global VP of Marketing located in Sweden, will assist the sales team for the Scandinavian region while still performing marketing and clinical support.


Markus D. our super salesperson in Germany is working hard to get our new distributor there up and running.  Manal H., based in the USA, is the glue that binds this team together.  She is always in the lead initiating new dynamics for the team and the Company.  Dr. Sabino Loiodice, who is our new Director of European Sales and Marketing,  has great experience along with the ideal European charm, maturity, and a very modern approach to management which embraces coaching, mentoring, and preempting obstacles. Expect great things from this super team.


Enzo Biochem ( ENZ: $ 6.92 )*


The activity in Enzo Biochem has shown it to be a rock star in the Biotech arena. Prior to the election the Biotech index was trading in Bear Market territory with many stocks having given up 50% or more from their 12 month highs. Enzo is up 47.56% for the year and up 56.6% for 12 months. The Relative strength index is close to 70 which is getting into overbought territory.


A small pullback has helped to move stock from weak to strong hands. Expect announcements of new product approvals from the New York regulatory agency for new Ampiprobe products filling in the pipeline for Women’s Health Care Products.  A  Scientific Paper on Enzo’s new line of products to allow for a more precise interpretation of tumor biopsies.


Updates on the Litigations in Delaware.


The last earnings report showed a cash position in excess of $65 million with no debt to speak of and a positive cash flow from their operating divisions. The only cash burn is coming from Litigation expenses and a bit from Research and Development. Litigation in Delaware  is on a contingency basis as such Enzo is not on the hook for billable hours. To my knowledge there are 6 suits left after 6 have settled.


When the company gets a 500 million dollar market cap ($10.63) they will qualify for those Institutions that can’t buy microcap stocks. A significant number of Institutions will look to be buyers and with only 47 million shares issued and Institutions already owning 50% and insiders owning 15% that leaves less than 17 million shares in the float.



Pressure BioSciences OTCQB: PBIO ( 0.20 )* 


PBIO has identified significant “needs” and the means to fill them in the world of today and the foreseeable future:


NEEDS IN MEDICINE: In the world of medicine our dramatically improved ability for early detection or to confirm and refine diagnosis ranging from over a hundred types of cancer to tuberculosis and a hundred other maladies and conditions is “bottlenecked” by 30 year old methods of preparing test samples.  Collectively such diagnostic samples exceed a hundred million annually.


NEEDS IN RESEARCH: Globally there are over a half a million medical and pharmaceutical research scientists working in over eighty thousand laboratories who are hampered by the time consuming and outdated methods of preparing test samples.


NEEDS IN FORENSICS: Globally, in millions of cases, swift and sure exoneration of the innocent and / or justice for the guilty is often delayed or even denied because of the ponderous means of preparing and conducting DNA and other forensic testing.


PBIO is focused on solving the challenges of biological sample preparation, a crucial laboratory step performed globally by the biological life sciences research scientists. Sample preparation refers to a wide range of activities that precede most forms of scientific analysis. It is often complex, time-consuming and, in our opinion, one of the most error-prone steps of scientific research. Sample preparation is a ubiquitous laboratory undertaking – the requirements of which drive a large and growing worldwide market. PBIO has developed and patented a novel, enabling technology platform that can control the sample preparation process while improving both efficacy and quality.  It is based on harnessing the unique properties of high hydrostatic pressure. This process, called pressure cycling technology, or PCT, uses alternating cycles of hydrostatic pressure between ambient (normal atmosphere) and ultra-high levels i.e., 35,000 pounds per square inch (“psi”) or greater to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.


The PBIO pressure cycling technology uses proprietary and internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures and specific time intervals, to rapidly and repeatedly control the interactions of bio-molecules, such as deoxyribonucleic acid (“DNA”), ribonucleic acid (“RNA”), proteins, lipids and small molecules.


Their laboratory instrument, the Barocycler®, and their internally developed consumables product line, which include Pressure Used to Lyse Samples for Extraction (“PULSE”) tubes, and other processing tubes, and application specific kits such as consumable products and reagents, together make up their PCT Sample Preparation System (“PCT SPS”).


The PBIO pressure cycling technology takes a unique approach that has the potential for broad use in a number of established and emerging life sciences areas, which include:


  • Biological sample preparation in potentially thousands of research laboratories worldwide working in human, animal, plant, and microbial diseases and disorders – including but not limited to sample extraction, homogenization, and digestion in genomic, proteomic, lipidomic, metabolomic and small molecule study areas;


  • Pathogen inactivation (useful in vaccine development, infectious disease research, and more);


  • Protein purification, and in the control of chemical reactions, particularly enzymatic (useful in drug design and development);


  • And immunodiagnostics (useful in the development and detection of biomarkers).




PBIO has secured their technology through fourteen issued United States patents and ten issued foreign patents covering multiple applications of pressure cycling technology in the life sciences field.  They also have additional patents pending.  Research indicates that Pressure BioSciences Inc is the ONLY Company globally to have patents in this new science sector.



Night Food, Inc. ( NGTF 0.20 )*


Night Food is a wholly-owned subsidiary of Night Food Holdings incorporated in Nevada in 2013 to manufacture and distribute healthy-choice bedtime snacks. The Company has an exclusive agreement with RFI, natural ingredient manufacturer and proprietor of Chocamine, a patented chocolate ingredient


Americans keep gaining more weight. People have the tendency to grab for goodies at the end of the evening as they relax to enjoy some T.V. Eating and snacking too late at night is a contributing factor to gaining weight. Seventy percent of adults, ages 18-54, eat right before bed. Chocamine delivers the health benefits of chocolate to the body (amino acids, minerals and polyphenols) without the added sugars, caffeine or fat.


People give in to the intense hunger cravings that leads to the consumption of sugary, salty or calorie dense foods to satisfy their appetite. Most of the snacks that people typically eat create a disturbance in sleep, causing a person to wake up feeling unrested. Night Food offers nutrient filled alternatives to high-calorie junk foods. There are flavor filled snack bars-either Cookies and Dreams or Midnight Chocolate Crunch that will help curb hunger, satisfy cravings, improve rest and give the body essential vitamins and minerals.


Consumers spend over $50 billion/ year on night-time snacks, nearly 1 billion a week.  More people desire healthy alternatives to late night consumption of the traditional fattening ice cream, chips and cookies.


Sugar and caffeine in most snacks causes disruptive sleep. Each bar has only 142 calories and 5 grams of fiber for slow absorption of energy and gives a feeling of fullness and satisfaction. There is also 132 mg of calcium and zinc for replenishing the body and feeling well rested in the morning.



Leo Motors ( LEOM: $ 0.0989 )*


LEOM has patents for the electric battery industry which we will be writing about in upcoming weekly reports. They have developed a lithium battery that can operate vehicles in sub-zero climates. Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats. They have a cartridge system which is a light-weight replacement method of swapping electric batteries.


Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.


In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN ( Controller Area Network ) based, which enables mobile diagnosing  between mobile devices and boats using the Leo technology.


Leo is developing a battery swap system for Kalmado in Puerto Princesa, Philippines, a world famous   tourist attraction, which is focused on green energy. They will be converting 100 boats as the environment is expected to become 100% free of the toxicity from internal combustion engines. Also, Leo has developed a battery swap system for Go-Karts to be used in malls in China, Korea and Myanmar. Leo Motors has a new carbon nanotube battery power pack that functions and supplies full power in extreme low temperatures such as below 49 degrees without the need for grid electricity.



Galaxy Gaming ( GLXZ: $ 0.58 )


Galaxy is on a nice growth pattern: They are in a great business with very little aggressive competition. They have some of the best development and manufacturing of table games and related products for the casino industry worldwide. Casino operators are in search for new and challenging table games to obtain increased interest and more funds from players.


Located in over 500 casinos around the globe, the Company offers a large portfolio of the world’s most popular side bets and proprietary table games. Additionally, the Company has a line of systems and associated equipment which provide casino operators with enhanced profitability, automation and security of table game operations.


best stocks to invest in now


Stocks To Invest In Now

Top Stocks To Invest In

Fundamental Analysis Stocks To Buy with Stops


Using fundamentals the following are stocks to trade hypothetically. They have done well. We have taken numerous profits as indicated on the table below. Balance is critical.


All of our stocks closed lower last week with the exception of Flushing Financial. FFIC continues to go North. Bank stock continue bullish into the new year. You must use your own discretion on whether to take profits.


The Boeing is still likely to test the $ 160 level in the new year.


We bought Bristol Myers at $49.20 with a stop loss at 47.42. We are bullish on BMY but would sell Calls on rallies to nail down some profit.


We sold the Amazon short  at  828 and covered on the opening November 8th. Continue to look at the short side on rallies with a buy stop above $ 775. $ 775 is the buy stop point if you remain short.


We are long FFIC at $ 19.10 and very much interested in buying the Flushing Financial.


The Hecla HL was stopped out at $ 5.64 on Dec 15th.


The HDGE is not relevant at this time.


We are looking to buy the GSCI symbol GSG, a commodity indexed fund managed by Goldman.

Symbol Name Business Description PE P/S MV mln Price Buy or Sell Limit Stop Loss

Or offset

GSG GSCI Commodity Indexed Fund 15.65 15.00 14.50x
TPC Tutor Perini Construction 12 0.25 1.3B 28.12 19.40


SAVE Spirit Airlines Discount Airline 13 1.6 3.6B 58.04  46.15 51.75sco
BMY Bristol Myers Biopharmaceutical Products 28 5.1 94.9B 58.49 49.20



Stopped out 12/07

AMZN Amazon Catalogue and Mail Order 200 3.18 388B   753.31 828 Sold Short

10/24 16

771.57 covered short 11/7 on opening
BA Boeing Aerospace, commercial jetliners, military systems 14 0.85 81B 155.51  Long at

   132 10/04/16      

Stop at 147.21
HL Hecla Mining Basic Materials 44 3.61 1.7B   5.32   6.21 5.64sco stopped out
FFIC Flushing Financial Bank Holding company Savings and loans 13 3,5 592Mln  29.49  19.10


AA Alcoa Aluminum Processing and Technology N/A 0.4 9.5B  28.03 21.15 originally bought 2/8/16 Sold at 29.20


Look to get long

VA Virgin Air Regional Airlines 7.2 0.9 1.5B 56.97 30.30



Sell to take profits
ENZ Enzo Biochem Life Sciences NA 1.35 134M  6.89 Bought

 at   5.13


Must hold 50 day m.a. at around $ 5.50

To be long

BAC Bank of America Commercial Bank 10 2.02 165.3B 22.12


Bought  at 15.42


HDGE Advisor Shares Ranger Bear ETF   9.24


 No Position currently Buy at 9.20

Sell at 8.88x



$100,000 Trading Portfolio Stock Positions and Trades


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.





Purchase Price Purchase Date Stop/Loss Price/Date Sold Profit/


GSK      200 37.52       12/06
GDX      150 20.99       12/05
GDX      150 20.65       12/05
SCO       20 69.05       12/01
SCO       20 74.41       11/30
RWM    100 50.60       11/21
ANW     500     10       11/17
DECK   100 54.48       12/28 60.90 11/15 $ 642
SPXU   200 22.88       11/14
CTL       150   23.29       11/04
AMBA   100   63.75       10/13
AA         167 31.29       07/25
MOS     200 27.53       05/02
EYES    500 5.04       04/04
EYES  1000 6.49       12/28
TWTR   200 28.51       10/28
MOS     100 43.55       08/14
SAN      600 8.40       12/16
AA        167 42.63       10/16
TEXQY* 200 6.56     7/11
REPR* 5000 0.22 10/22/12


Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.

For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.



Stocks To Invest In Now

Best Stocks To Invest In

Market Strategies $100,000 Trading Account


There were two closed options positions and one closed stock position.


The 8 VRX Calls were sold at a loss of $ 296.

The NVDA Calls made profit of $ 1480.

There remain two open 8-lot options positions: the AMBA and LMT Calls.

The DECK covered at $ 54.48 gained $ 642.


The net for the week was a gain of $ 1,826.


For the entire year on closed out trades, our hypothetical profits were

increased by $ 1,826 to $27,902.


Open trade losses decreased to $15,874.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 20 positions:


AA ( 2 ), AMBA, ANW, CTL, EYES( 2 ), GDX ( 2 ) GSK, MOS ( 2 ),



The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.



Money management is based on a hypothetical $ 100,000.

The 20 stock positions would cost $ 85,470.

The options positions require $ 1,672,

making a total of $ 87,142.

That leaves a profit of $ 12,858 when considering the $ 100,000 deposit.


These figures are approximate and there might be errors.


We have not counted the dividends received from many previous trades such as Apple, Colgate Palmolive, JP Morgan, Mosaic, North American Tankers, STNG, Santander, which pays over 5%, their Brazil affiliate BSBR and Blue Capital Reinsurance which was sold for a profit and many others.


The trading is hypothetical and we do not count commission costs.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:





Go To

To get the lowest full membership rates available now.


Best Stocks To Invest In

Top Stocks To Invest In

Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price



Option Cost Date Sold Date Profit/


AMBA Jan 57

8 lots



NVDA Jan 115

2 lots



12/27/16 12.40 12/29/2016 $ 1480
LMT Jan 260

8 lots



VRX Dec 30th 14

8 lots



12/16/16 0.37

( 50% Loss Rule )

12.27/2016 ( $ 296 )



Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.



MARKET Laboratory – Weekly Changes


Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.










S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





150-21 + 1-17

3.10% -0.06%

10 Yr. Note

124-09 +296  2.52%-0.05%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

117-212 +188

2.01% -0.05%






DJ Utilities
























M1 Money



Dec 19th


M2 Money



Dec 19th



* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.



Market Strategies Technical Information


                              Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500              2207                                     2279

Dow                  19,555                                  19,980

QQQ             116.55                                  121.20

Transports          9040                                     9365

NASDAQ            5397                                 5505



This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information



New Year’s Day is observed. Financial Markets are closed


The Rose Bowl Football Game will follow a tightly policed parade in Pasadena, Cal, with water barricades for preventing terror attacks.


The U.S Congress returns to work.

10:00 hrs Construction Spending November ( 0.5% vs 0.5% )

10:00 hrs ISM Index December ( 53.6 vs 53.2 )

Faraday Future, a  would-be challenger to Tesla, shows its coming car in Las Vegas before the CES opening

The Anthem-Signa antitrust trial, in which the Dept of Justice seeks to prevent the health-care companies’ merger, resumes in D.C.

WEDNESDAY UniFirst UNF ( 1.57 vs 1.78 )

07:00 hrs MBA Mortgage Index 12/31 ( NA vs +2.5% )

14:00 hrs Auto Sales December ( NA vs 5.21Mln )

14:00 hrs Truck Sales December ( NA vs 8.92 Mln )

14:00 hrs FOMC Minutes December ( NA ).


Landec LNDC ( 0.07 vs 0.07 ) Mistras Group MG ( 0.31  vs 0.39 ) MTS Systems MTSC

( 0.75 vs 0.61 ) Resources Connection RECN ( 0.19 vs 0.23 ) Sonic SONC ( 0.21 vs 0.24 )


THURSDAY Constellation Brands STZ ( 1.71 vs 1.42 ) Monsanto MON ( -0.02 vs -0.11 ) RPM Inc RPM

( 0.61 vs 0.62 ) Schnitzer Steel SCHN ( -0.04 vs -0.13 ) Walgreens  WBA ( 1.09 vs 1.03 )

07:30 hrs Challenger Job Cuts December ( NA vs -13.0% )

08:15 hrs ADP Employment Change December ( 170K vs 216K )

08:30 hrs Initial Unemployment Claims 12/31 ( 265K vs 265K )

08:30 hrs Continuing Unemployment Claims 12/24 ( NA vs 2102K )

10:00 hrs ISM Services December ( 56.6 vs 57.2 )

10:30 hrs Natural Gas Inventories 12/31 ( NA vs -237 bcf )

11:00 hrs Crude Inventories 12/30 ( NA vs 0.600Mln Bbls )

 Helen of Troy HELE ( 1.86 vs 2.07 ) PriceSmart PSMT ( 0.82 vs 0.78 )

FRIDAY AngloDynamics ANGO 0.16 vs 0.14 AZZ AZZ ( 0.87 vs 0.91) Greenbrier GBX

( 0.83 vs 2.15 )

08:30 hrs Nonfarm Payrolls December ( 175K vs 178K )

08:30 hrs Nonfarm Private Payrolls December ( 170K vs 156K )

08:30 hrs Unemployment Rate December ( 4.7% vs 4.6% )

08:30 hrs Hourly Earnings December ( +0.3% vs -0.1% )

08:30 hrs Average Workweek December ( 34.4hrs vs 34.4hrs )

08:30 hrs Trade Balance November ( -$42.2Bln vs -$42.6Bln )

10:00 hrs Factory Orders November ( -2.1% vs +2.7% )

Biogen’s planned spinoff, Bioverativ, hosts an investor day ahead of the hemophilia treatment unit’s separation from its parent.

The U.S. Oil Rig Count increased by 2 Rigs to 525. The Nat Gas rig count increased by 3 to 132, and there is one rig listed as miscellaneous making a total US rig count of 658. . Crude closed higher at $ 53.72 up $ 0.70.The total rig count is lower by 42 from a year earlier. Natural Gas closed the week higher for the week, up 0.046 or + 1.3% at $3.724.



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:





Go To

To get the lowest full membership rates available now.



Market Strategies Fundamentals


The post-holiday week saw a wider trading range than the pre-holiday stretch, but fewer investors took part in last week’s action, making it easier to push the market around. The S&P 500 lost 1.1% after spending the week in a 40-point range (vs 17 points in the prior week) while average daily NYSE floor volume was just 758 million shares vs 853 million two weeks ago. The benchmark index finished ahead of the Nasdaq Composite (-1.5%), but behind the Dow Jones Industrial Average (-0.9%) and the Russell 2000 (-1.0%).


The Santa Claus cycle, a weeks’ duration, began December 22nd and extends for the first two days trading days of January. All three major indexes, the Dow, S&P and DJ Transportation are at a loss so far. The Dow is off 156.28; the S&P is minus 22.13 and the Tranny is off 115.74. The adage says” If Santa should fail to call, bears may come to “ Broad and Wall.”


The abbreviated week started on an unassuming note with the S&P 500 rising 0.3% while the Nasdaq (+0.5%) outperformed. The Tuesday session saw the lowest volume of the week and almost everyone’s attention was on the technology sector (+0.6%) where NVIDIA (NVDA) surged 6.9%. The move was not owed to any particular news item, but it called attention to the stock’s meteoric rise in 2016. Tuesday’s surge extended NVIDIA’s 2016 gain to 256.0%.


DJIA 19933.81 19762.60 -171.21 -0.9 13.4
Nasdaq 5462.69 5383.12 -79.57 -1.5 7.5
S&P 500 2263.79 2238.83 -24.96 -1.1 9.5
Russell 2000 1371.51 1357.13 -14.38 -1.0 19.5


Dow Jones Transportation Average ( DJT: $ 9051.02 ) fell 99.62 points last week after leading all indexes down as its downtrend began December 12th. The Tranny is usually the leader and makes the initial first directional move.

US dollar ( DXYO: 102.64 -0.42 ) last week after trading sideways in a consolidation pattern for two weeks since December 15th. During this period the dollar has traded between 102.50 and 103.65. closing the year at the lower part of the range.

Volatility ( VIX: $14.04  +2.60 ) gained 22.7%  last week, which also led to lower stock prices. The Pro-Shares Ultra Vix Short-Term volatility futures ( UVXY: $ 8.69 ) + 0.80 or gaining 10.1%. The VIX fell to 11 in 2009 before rallying to 90. In 2013 it rallied to 22 from 10; in 2014 the VIX got up to 55; in 2015 it got to 53; last year it doubled to 23.

Crude OIL ( 53.72 ) gained $ 0.70 or +1.3% in the holiday-shortened week. The Rig count increased by 5 to 658; now only 42 rigs below 2015 levels.Oil rigs increased by 2 to 525 and Natural Gas by 3 to 132.

Next week is a big week for data with only four days of trading. The ISM Index is the first of many major reports coming Tuesday, a closely-watched number, with continuing strength expected. Auto and Truck sales come Wednesday, followed by .FOMC minutes.  Initial claims comes Thursday and is a closely watched indicator for short-term trends. Then, Friday brings the Employment report, by far the most important of all economic reports and will set in motion direction for the stock indexes. As it becomes harder to fulfill employment numbers, the participation rate will be closely watched along with the direction of wages.






While the P/E at 24 is very high, calling the top has been treacherous as shown in the following chart.





Market Strategies Economic Data

The Consumer Confidence Index from the Conference Board surged to 113.7 in December ( consensus 109.8) from an upwardly revised 109.4 (from 107.1) in November.

Key Factors

December marked the highest reading for the index since August 2001.

The Expectations Index is at a 13-year high, driven by post-election optimism related to the economic outlook, jobs, income prospects, and stock prices, which the Conference Board said was highest among older consumers.

The Present Situation Index was weighed down partly by an appraisal of the labor market that was less positive than the one made in November. The outlook for the labor market improved noticeably, though, as the proportion of consumers expecting more jobs in the months ahead increased from 16.1% to 21.0%.

The key takeaway from the report is that the uptick was driven entirely by the Expectations Index, which increased from 94.4 to 105.5. The Present Situation Index decreased from 132.0 to 126.1.

Conference Board 113.7 109.4 100.8 103.5 101.8
  Expectations 105.5 94.4 86.0 87.2 86.1
  Present Situation 126.1 132.0 123.1 127.9 125.3
Employment (‘plentiful’ less ‘hard to get’) 4.4 6.6 3.6 5.3 4.0
1 yr inflation expectations 4.5% 4.8% 4.8% 5.0% 4.8%



The Chicago PMI a popular business barometer slipped to 54.6 in December ( consensus 55.2) from 57.6 in November, which was the highest reading for the barometer since January 2015. The dividing line between expansion and contraction for the barometer and the component indexes is 50.0.

The Production Index dipped from 59.1 to 58.5 while the Employment Index held steady at 49.7.

The Prices Paid Index rose from 56.8 to 58.0, which was the second highest reading in 2016.

Notwithstanding the dip, the fourth quarter average of 54.3 for the barometer is the highest it has been in two years.

The downturn in December was led by a drop in the New Orders Index from 63.2 to 56.5, a decline in the Order Backlogs Index from 52.8 to 42.6, and a drop in the Inventories Index from 56.1 to 46.0.

The key takeaway from the report is that over half of the respondents to a special question pertaining to the 2017 outlook said they expected their business to prosper, aided by tax reforms and deregulation.

Chicago PMI 54.6 57.6 50.6 54.2 51.5
New Orders 56.5 63.2 52.5 54.1 53.9
Production 58.5 59.1 54.4 59.8 52.5
Employment 49.7 49.7 51.1 49.2 53.7
Prices Paid 58.0 56.8 59.5 55.5 54.6



Stock Market Investing News

Stocks To invest in now

Market Strategies Cycles


January has quite a legendary reputation on Wall Street as an influx of cash from yearend bonuses and annual allocations typically propels stocks higher. January ranks #1 for NASDAQ (since 1971), but sixth on the S&P 500 and DJIA since 1950. It is the end of the best three-month span and possesses a full docket of indicators and appropriate seasonal occurrences. The full year 2016 did not perform as expected as the full year was not expected to be a banner year for so many markets. The election year and surprising list of high-qualified very successful, non-political and wealthy appointees, like Carl Icahn and Wilbur Ross, by the new president has made a difference.


On January 20, 2016 the Dow collapsed to 15,450.56. Around the same time The S&P 500 fell to 1812, while the NASDAQ dropped to 4212. Not to be outdone, The Dow Jones Transportation index fell to 6403 on the same date as the Dow low.


DJIA and S&P January rankings have slipped precipitously. The month has suffered some significant disparities and losses over the last 17 years. From 2000 to 2016 both indices declined 10 times; three in a row from 2008 to 2010 and again 2014 to 2016. January 2009 has the dubious honor of being the worst January on record for DJIA (-8.8%) and S&P 500 (-8.6%) since 1901 and 1931 respectively.


On pages 106 and 110 of the Stock Trader’s Almanac 2017 there is an illustration of the January Effect, where small caps begin to outperform large caps, actually starts in mid-December.

Early signs of the January Effect can be seen by comparing iShares Russell 2000 (IWM) to SPDR S&P 500 (SPY) over the past few trading sessions. IWM is up around 2% since December 14 compared to a 0.2% gain for SPY. The majority of small-cap outperformance is normally done by mid-February, but strength can last until mid-May when most indices reach a seasonal high.


The first indicator to register a reading in January is the Santa Claus Rally. The seven-trading day period begins on the open on December 23 and ends with the close of trading on January 4. Normally, the S&P 500 posts an average gain of 1.4%. The failure of stocks to rally during this time tends to precede bear markets or times when stocks could be purchased at lower prices later in the year. Last year, there was no Santa Claus Rally and S&P 500 dropped 5.1% in the month of January before bottoming and rebounding in February.


On January 9, our First Five Days “Early Warning” System will be in. In post-presidential election years this indicator has a solid record. In the last 16 post-presidential election years 12 full years followed the direction of the First Five Days. The full-month January Barometer has a presidential-election-year record of 13 of the last 16 full years following January’s direction.


The flagship indicator, the January Barometer created by Yale Hirsch in 1972, simply states that as the S&P goes in January so goes the year. It came into effect in 1934 after the Twentieth Amendment moved the date that new Congresses convene to the first week of January and Presidential inaugurations to January 20.


The long-term record has been very good with an exception of the past tumultuous election year, an excellent accuracy rate, with only nine major errors in 65 years.  Election years are an exception. This year will set up to function better.


Major errors occurred in the secular bear market years of 1966, 1968, 1982, 2001, 2003, 2009, 2010, 2014 and 2016. The market’s position on January 31 will hopefully provide a good read on the year to come. When all the Santa Claus Rally, the First Five Days and January Barometer are in agreement, it has been prudent to heed their call.


  DJI SP500 NASDAQ Russell 1K Russell 2K
Rank 6 6 1 7 5
# Up 42 40 29 23 20
# Down 25 27 17 15 18
Average % 0.9 0.9 2.5 0.9 1.4
4-Year Presidential Election Cycle Performance by %
Post-Election 0.7 0.7 2.2 1.6 2.0
Mid-Term -0.9 -1.0 -0.7 -1.3 -0.9
Pre-Election 3.7 3.9 6.6 2.9 3.2
Election -0.01 0.2 1.7 0.1 1.2
Best & Worst January by %
Best 1976 14.4 1987 13.2 1975 16.6 1987 12.7 1985 13.1
Worst 2009 -8.8 2009 -8.6 2008 -9.9 2009 -8.3 2009 -11.2
January Weeks by %
Best 1/9/76 6.1 1/2/09 6.8 1/12/01 9.1 1/2/2009 6.8 1/9/87 7.0
Worst 1/8/16 -6.2 1/8/16 -6.0 1/28/00 -8.2 1/8/16 -6.0 1/8/16 -7.9
January Days by %
Best 1/17/91 4.6 1/3/01 5.0 1/3/01 14.2 1/3/01 5.3 1/21/09 5.3
Worst 1/8/88 -6.9 1/8/88 -6.8 1/2/01 -7.2 1/8/88 -6.1 1/20/09 -7.0
First Trading Day of Expiration Week: 1990-2016
#Up-#Down 17-10 13-14 12-15 11-16 11-16
Streak U1 U1 D4 D4 D4
Avg % -0.01 -0.04 -0.01 -0.1 -0.1
Options Expiration Day: 1990-2016
#Up-#Down 16-11 15-12 14-13 15-12 15-12
Streak U6 U2 U2 U2 U2
Avg % -0.01 -0.01 -0.1 -0.01 -0.01
Options Expiration Week: 1990-2016
#Up-#Down 14-13 10-17 15-12 10-17 14-13
Streak U1 U1 U1 U1 U1
Avg % -0.3 -0.2 -0.01 -0.2 -0.04
Week After Options Expiration: 1990-2016
#Up-#Down 13-14 16-11 14-13 16-11 19-8
Streak U2 U2 U2 U2 U2
Avg % -0.4 -0.2 -0.1 -0.2 0.1
January 2017 Bullish Days: Data 1996-2016
January 2017 Bearish Days: Data 1996-2016



For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To:





Go To

To get the lowest full membership rates available now.


Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000


Charles Moskowitz

 (781) 826-8882


Princeton Research

3887 Pacific Street, Las Vegas, Nevada 89121


Where to invest market strategies

Stock Market Investing News

Market Strategies Newsletter


stocks to invest in now

best stocks to invest in

top stocks to invest in

best option trading strategies

options trading alerts